Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker.

Shaohua ZhanJinming LiTianxiao WangWei Ge

Published in: The oncologist (2018)

Proteomic dissection and prognostic biomarkers are scarce in sporadic medullary thyroid cancer (MTC). This article reports the use of proteomics technology to comprehensively investigate the molecular mechanisms of sporadic MTC, which resulted in the identification of FN1 as a novel candidate prognostic biomarker.

Keyphrases

late onset
amyotrophic lateral sclerosis
mass spectrometry
label free
high resolution
early onset
risk assessment